Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma

Condition:   Kaposi Sarcoma Intervention:   Drug: Talimogene laherparepvec Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting

Source: ClinicalTrials.gov - August 22, 2019 Category: Research Source Type: clinical trials